
HG-14-10-04
CAS No. 1356962-34-9
HG-14-10-04( HG-14-10-04 )
Catalog No. M17255 CAS No. 1356962-34-9
HG-14-10-04 is a potent and specific ALK inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 73 | In Stock |
![]() ![]() |
5MG | 113 | In Stock |
![]() ![]() |
10MG | 186 | In Stock |
![]() ![]() |
25MG | 266 | In Stock |
![]() ![]() |
50MG | 332 | In Stock |
![]() ![]() |
100MG | 478 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameHG-14-10-04
-
NoteResearch use only, not for human use.
-
Brief DescriptionHG-14-10-04 is a potent and specific ALK inhibitor.
-
DescriptionHG-14-10-04 is a novel potent and specific ALK inhibitor.
-
In VitroHG-14-10-04 (example 10) has inhibitory activity against ALK kinase with an IC50 of 20 nM.HG-14-10-04 (compound 17b) exhibits kinase inhibitory activity against EGFRLR/TM, EGFR19del/TM/CS and EGFRLR/TM/CS with IC50s of 15.6 nM, 22.6 nM and 124.5 nM, respectively.
-
In Vivo——
-
SynonymsHG-14-10-04
-
PathwayGPCR/G Protein
-
TargetLPA Receptor
-
RecptorALK
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1356962-34-9
-
Formula Weight532.08
-
Molecular FormulaC29H34ClN7O
-
Purity>98% (HPLC)
-
SolubilityDMSO : 13.3 mg/mL. 25.00 mM;
-
SMILESCN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(c5c[nH]c6c5cccc6)n4)c(OC)c3)CC2)CC1
-
Chemical Name[5-Chloro-4-(1H-indol-3-yl)-pyrimidin-2-yl]-{2-methoxy-4-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-phenyl}-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.U.S. Pat. Appl. Publ. (2012), US 20120028924 A1
molnova catalog



related products
-
ONO-7300243
ONO-7300243 is an antagonist of lysophosphatidic acid receptor 1 (LPA1; IC50 : 0.16 μM).
-
Ki16198
Ki16198 is the methyl ester of Ki16425 which is a LPA antagonist and inhibits LPA1- and LPA3-induced inositol phosphate production with Ki of 0.34 μM and 0.93 μM.
-
TAK-615
TAK-615 is commonly used to study pulmonary fibrosis and is a negative allosteric modulator of LPA1 receptors.